JG
CBAY

Joel Greenblatt’s Cymabay Therapeutics CBAY Stock Holding History

Joel Greenblatt’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,081
Closed -$451K – 1479
2023
Q4 		$451K Sell
19,081
-21,381
-53% -$381K 0.01% 1023
2023
Q3 		$603K Buy
+40,462
New +$536K 0.01% 924

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Joel Greenblatt's CBAY Position: Q1 2024 in Review

Joel Greenblatt sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 19,081 shares — an estimated $451K sold.

Joel Greenblatt first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $603K in Q3 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Joel Greenblatt reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Joel Greenblatt sold 19,081 Cymabay Therapeutics shares in Q1 2024, an estimated $451K.
  • Joel Greenblatt first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Joel Greenblatt's Cymabay Therapeutics position peaked at $603K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Gotham Asset Management's 13F filing for Q1 2024, filed 15 May 2024.